Key result
Antidepressant drugs used in patients with cardiovascular diseases require careful evaluation of cardiovascular adverse reactions and drug interactions with cardiovascular medications.
Why the study?
Depression frequently co-occurs with cardiovascular diseases and worsens prognosis, raising concerns regarding the efficacy, safety, and cardiovascular adverse reactions of increasingly used antidepressant drugs.
Clinicians must carefully evaluate cardiovascular adverse reactions and drug interactions when prescribing antidepressants to patients with cardiovascular diseases.
Requires caution monitoring cardiovascular effects of antidepressants in CVD patients; leaves open optimal selection pending higher-level evidence.
Depression has a high incidence in patients with cardiovascular diseases (CVD) and shows adverse effects on their life quality and prognosis. With the advent of new antidepressant drugs, oral antidepressant drugs are increasingly used in CVD patients with depression, and their efficacy and safety have attracted attention. Commonly used antidepressant drugs have many adverse reactions. When applying antidepressant drugs in CVD patients, we should pay special attention to their cardiovascular adverse reactions and their interaction drugs with commonly used CVD drugs. Clinicians should comprehensively evaluate and select appropriate antidepressant drugs for patients.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2020) conducted a review in Cardiovascular diseases with depression. Antidepressant drugs was evaluated. Antidepressant drugs used in patients with cardiovascular diseases require careful evaluation of cardiovascular adverse reactions and drug interactions with cardiovascular medications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: